ArticleScientific reports2018

Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes.

John-Michael Gamble et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.